Clinical Trials Logo

Pneumonia clinical trials

View clinical trials related to Pneumonia.

Filter by:

NCT ID: NCT01498601 Completed - Pneumonia Clinical Trials

Improving Oral Care to Reduce Hospital-Acquired Pneumonia (HAP) in the Acute Neurologically Impaired Adult

Start date: January 2012
Phase: N/A
Study type: Interventional

Hypothesis: The investigators hypothesize that the current oral protocol is sub-optimal and an enhanced protocol will decrease the incidence of hospital acquired pneumonia (HAP)in the acute, non-intubated, care-dependent, neurologically impaired, adult patient.

NCT ID: NCT01489124 Completed - Clinical trials for Ventilator-Associated Pneumonia

The Population Pharmacokinetics of Imipenem in Patients With Ventilator-associated Pneumonia

Start date: January 2008
Phase: Phase 4
Study type: Interventional

This is prospective, randomized and crossover design to assess the pharmacokinetic and pharmacodynamics of three regimen. - 0.5-hr infusion of imipenem 0.5 g every 6 hrs - 2-hr infusion of imipenem 0.5 g every 6 hrs - 2-hr infusion of imipenem 1 g every 6 hrs Clinical and laboratory data such as Age,Sex, Body weight, CBC, Electrolyte, Vital signs, APACHE II score, BUN, Cr, Sample and Blood culture will be collected. Nine patients will be enrolled in this study. After completion of the imipenem therapy for 3 days in this study, all patients will receive other sensitive antibiotics to eradicate their bacterial infections. Blood samples (approximately 3 ml) will be obtained by direct venepuncture at the following time: 0, 0.5, 1, 2, 3, 4, 5 and 6 after 4th dose of imipenem. Concentration of imipenem in plasma will be measured by HPLC method. Then, the data will be simulated in Monte Carlo technique (Computer model) to get PK/PD index (40%T>MIC) and reported to % PTA (Probability Target Attainment) and %CFR (Cumulative Faction Response).

NCT ID: NCT01487850 Completed - Clinical trials for Hypersensitivity Pneumonitis

Wind Instruments' Fungal Contamination

Start date: May 2007
Phase: N/A
Study type: Interventional

On the basis of 2 cases of immunologically-induced lung disease in 2 saxophonists, the investigators supposed that wind reed instruments could be contaminated with molds. The investigators led a study on 40 musicians playing a wind reed instrument to analyze instruments' fungal contamination and its immunological and clinical consequences for musicians.

NCT ID: NCT01477099 Completed - Clinical trials for Ventilator Associated Pneumonia

Toothbrushing and Ventilator-associated Pneumonia

Start date: August 2010
Phase: Phase 4
Study type: Interventional

The hypothesis is that adding the toothbrushing to the oral care with clorhexidine 0.12% could be reduce the incidence of ventilator-associated pneumonia due to that oral cavity may be an important reservoir of pathogens that could cause pneumonia.

NCT ID: NCT01476995 Completed - Hypertension Clinical Trials

Prognostic Indicators as Provided by the EPIC ClearView

GBMC
Start date: September 2010
Phase: N/A
Study type: Observational

The objective of this study is to determine whether the finger tip images captured by the EPIC ClearView device, when analyzed via the ClearView software, produce a Response Scale that characterizes trends consistent with known diagnoses identified by medical doctors. Specifically, the investigators hypothesize that the organ system involving any of a series of known active diagnoses will be identified in the EPIC ClearView Response Scale report with the intention of providing potential triage capabilities.

NCT ID: NCT01476254 Completed - Pneumonia Clinical Trials

Respiratory Complications After Laparoscopic Surgery

Start date: November 2011
Phase: N/A
Study type: Observational

The purpose of this study is to describe the magnitude of respiratory complications after laparoscopic hysterectomy and cholecystectomy.

NCT ID: NCT01467648 Completed - Clinical trials for Ventilator-Associated Pneumonia

The Pharmacodynamics of Doripenem Between 4-hour and 1-hour Infusion in Patients With Ventilator-associated Pneumonia

Start date: October 2010
Phase: Phase 4
Study type: Interventional

This is prospective and randomized study to assess the pharmacodynamics (t>MIC) of 0.5 g every 8 h of doripenem in patients with VAP following administration by a 4 h infusion or 1 h infusion. Clinical and laboratory data such as Age,Sex, Body weight, Electrolyte, Vital signs, APACHE II score, BUN, Cr, Blood culture will be collected. Twelve patients will be enrolled in this study. After completion of the doripenem therapy for 3 days in this study, all patients will receive other sensitive antibiotics to eradicate their bacterial infections. Doripenem pharmacokinetic study will be carried out during the doripenem therapy. Blood samples (approximately 2 ml) in group " 0.5 g of doripenem with 4 h infusion every 8 h regimen" will be obtained by direct venepuncture at the following time: 0, 0.5, 1, 2, 3, 4, 4.5, 5, 6, 7 and 8 h after 7th dose of doripenem. Blood samples (approximately 2 ml) in group " 0.5 g of doripenem with 1 h infusion every 8 h regimen" will be obtained by direct venepuncture at the following time: 1, 1.5, 2, 4, 5, 6, 7 and 8 h after 7th dose of doripenem. The doripenem assays by method of Ikeda K et al. (J Chromatogr B, 2008) will be performed. Concentration of doripenem in plasma will be simulated in Monte Carlo technique (Computer model) to get PK/PD index (40%T>MIC) and reported to % PTA (Probability Target Attainment) and %CFR (Cumulative Faction Response)

NCT ID: NCT01457248 Completed - Clinical trials for Postoperative Pneumonia

Taper-shaped Cuff Endotracheal Tube Against Respiratory Infections

TETRIS
Start date: October 2011
Phase: N/A
Study type: Interventional

The incidence of postoperative pneumonia after aortic surgery reaches 60%. In experimental lung model, endotracheal tube with taper-shaped cuff has been shown to decrease microaspiration. This effect has never been demonstrated in patients. The investigators hypothesize that use of endotracheal tube with taper-shaped cuff decreases the incidence of postoperative pneumonia in patients after aortic surgery.

NCT ID: NCT01446926 Completed - Pneumonia Clinical Trials

Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants

Start date: September 2011
Phase: Phase 1
Study type: Interventional

This study is designed to explore the safety and tolerability of an investigational pneumococcal vaccine through a step-down enrollment. Primary Objective: - To evaluate the safety and tolerability of an investigational pneumococcal vaccine. Secondary Objective: - To evaluate the immunogenicity of an investigational pneumococcal vaccine.

NCT ID: NCT01444352 Completed - Clinical trials for Pneumococcal Infections

Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults

Start date: June 2010
Phase: Phase 1
Study type: Interventional

This study is designed to evaluate the safety, tolerability, and immunogenicity of an investigational pneumococcal vaccine in healthy adult volunteers. Primary Objective: - To evaluate the safety and tolerability of an investigational pneumococcal vaccine. Observational Objective: - To evaluate the immunogenicity of an investigational Pneumococcal vaccine.